Clinical Trial

Nodal Downstaging Versus Primary Tumor Regression as Predictors of Survival After Total Neoadjuvant Therapy for Rectal Cancer: A Retrospective Study

Name: Nodal Downstaging Versus Primary Tumor Regression as Predictors of Survival After Total Neoadjuvant Therapy for Rectal Cancer: A Retrospective Study — clinical trial record (NCT07557316)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

To evaluate the prognostic impact of post-TNT pathological nodal status (ypN) on LRFS, DMFS, and OS, and compare it with that of primary tumor response

Trial Details

NCT Number	NCT07557316
Lead Sponsor	Sohag University
Conditions	Rectal Cancer Patients, Total Neoadjuvant Therapy
Enrollment	100 participants
Start Date	2026-05-10
Primary Completion	2027-03-10 (estimated)
Study Completion	2027-05-10 (estimated)
Updated on ClinicalTrials.gov	2026-04-29